InvestorsHub Logo
Followers 4
Posts 37
Boards Moderated 0
Alias Born 01/19/2019

Re: None

Wednesday, 05/01/2019 5:49:25 PM

Wednesday, May 01, 2019 5:49:25 PM

Post# of 232886
I added a number of additional shares today because:

1. It is very difficult for anyone to dispute that Leronlimab is a very valuable asset. It is worth mutliple times the current CYDY market cap. I haven't heard anyone dispute that.
2. It is hard for me to imagine any scenario where CYDY shareholders don't realize at least some gain from Leronlimab whether through a buyout or through licensing deals. Everything will have to align for it to be a homerun, but a nice double seems very likely.
3. Management continues to overpromise and underdeliver on timelines which has created a lot of frustration and fear in current shareholders and potential investors. I understand this frustration, but the reality is nothing has changed. Leronlimab is still a very valuable asset. There could be more downside but sentiment is very negative right now. Fear and frustration has created a pretty strong buying opportunity. JMHO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News